Maximilien Levesque

Founder

Now Founder, Aqemia

Latest on AI4S.fyiTimeline · Jul 17Sanofi nominates a new target in its Aqemia collaboration, triggering a milestone payment of undisclosed size

Account linked from x.com/aiforhealthfr · Avatar from their X account, taken 2026-09-28

Affiliations

Current

Founder · Aqemiasince 2019nasdaq.com ↗

Current roles come from these dated records, not from the bio below. Each links the page it was read from.

About

Maximilien Levesque is co-founder and CEO of Aqemia, which combines physics-based computation with generative AI to design drug molecules. He holds a PhD in quantum physics from CEA Saclay (2010), did postdoctoral research at Oxford and Cambridge, and from 2013 led a mathematical physics research group at ENS and CNRS. In 2019 he left his post as a full professor to co-found Aqemia with Emmanuelle Martiano-Rolland.

Read on 2026-09-29; for current roles see Affiliations above. Read at: aqemia.com ↗

Founded

AqemiaDrug discovery · 2019 · 3 rounds on record · disclosed $38M + €60M · Round (unnamed) $38M
Background: École normale supérieure (physics research; Aqemia is an ENS spin-out) (as the company's own announcements put it)
Co-founders: Emmanuelle Martiano
Backed byCathay Innovation Wendel Growth Eurazeo Bpifrance Large Venture

On the timeline

2026-07-17Sanofi nominates a new target in its Aqemia collaboration, triggering a milestone payment of undisclosed size

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →